Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux.

[1]  W. Snodgrass,et al.  Multivariate analysis of factors predicting success with dextranomer/hyaluronic acid injection for vesicoureteral reflux. , 2007, The Journal of urology.

[2]  E. Garin,et al.  Clinical Significance of Primary Vesicoureteral Reflux and Urinary Antibiotic Prophylaxis After Acute Pyelonephritis: A Multicenter, Randomized, Controlled Study , 2006, Pediatrics.

[3]  J. Pope,et al.  Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. , 2006, The Journal of urology.

[4]  J. Craig,et al.  Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled trials , 2003, Archives of disease in childhood.

[5]  P. Caione,et al.  Dextranomer/hyaluronic acid copolymer implantation for vesico-ureteral reflux: a randomized comparison with antibiotic prophylaxis. , 2002, The Journal of pediatrics.

[6]  E. Hanson,et al.  Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long-term antibacterial prophylaxis. The International Reflux Study in Children. , 1992, The Journal of urology.

[7]  R. Weiss,et al.  Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children. , 1992, The Journal of urology.

[8]  S. Wikström,et al.  Surgical results in the International Reflux Study in Children (Europe). , 1992, The Journal of urology.